Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/12/25 17:30 | 9/11/25 | CYRX | Health | Drug | Pharmaceutical Preparations | Hariri Robert J | TN | D | 3 | M.d | 419 | 5.23 | 0 | 80 | 51 | D | ||||||||||||||||
9/12/25 17:30 | 9/11/25 | CYRX | Health | Drug | Pharmaceutical Preparations | Hariri Robert J | TN | D | 3 | S.d | -419 | 5.23 | 0 | -80 | 51 | D | ||||||||||||||||
8/21/25 17:00 | 8/19/25 | CYRX | Health | Drug | Pharmaceutical Preparations | Stefanovich Robert | TN | O | CFO | 2 | M.d | 161 | 4.54 | 0 | 35 | 21 | 207 | D | ||||||||||||||
8/21/25 17:00 | 8/19/25 | CYRX | Health | Drug | Pharmaceutical Preparations | Stefanovich Robert | TN | O | CFO | 2 | S.d | -161 | 4.54 | 0 | -35 | 207 | D | |||||||||||||||
8/15/25 17:00 | 8/13/25 | CYRX | Health | Drug | Pharmaceutical Preparations | Shelton Jerrell | TN | DO | P,CEO | 3 | M.d | 375 | 5.00 | 0 | 75 | 8 | 1,062 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |